Can inhibition of IKur promote atrial fibrillation?

被引:41
作者
Burashnikov, Alexander [1 ]
Antzelevitch, Charles [1 ]
机构
[1] Masonic Med Res Lab, Utica, NY 13501 USA
关键词
atrial fibrillation; antiarrhythmic agents; action potential;
D O I
10.1016/j.hrthm.2008.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Block of ultrarapid delayed rectified potassium current (I-Kur), present in atria but not in ventricles, is thought to be a promising approach for atrial-specific therapy of atrial fibrillation (AF). However, it has been shown that I-Kur block may abbreviate atrial repolarization and that Loss-of-function mutations in KCNA5, which encodes K-v 1.5 channels responsible for I-Kur is associated with familial AF. OBJECTIVE Our objective in this study was to use low concentrations of 4-aminopyridine (4-AP, 10 to 50 mu M), known to selectively block I-Kur to assess the proarrhythmic and antiarrhythmic effects of I-Kur block in healthy and remodeled atria. METHODS Isolated canine coronary-perfused right atrial preparations were used. Acetylcholine or ischemia/reperfusion was used to acutely remodel the atria. Transmembrane action potentials and a pseudo-etectrocardiogram were simultaneously recorded. RESULTS Normal (healthy) atria typically displayed action potentials (AP) with a prominent plateau, whereas remodeled atria displayed triangular-shaped APs (remodeled). In healthy atria, in which AF could not be induced with programmed stimulation, 4-AP abbreviated action potential measured at 90% repolarization (APD(90)) and effective refractory period (ERP), permitting the induction of AF in 4 of 12 preparations (33%). In remodeled atria, 4-AP produced Little (50 mu M) to no (10 to 25 mu M) prolongation of APD(90) or ERP and was either ineffective or poorly effective in terminating AF or preventing its induction. CONCLUSION Our findings suggest that block of I-Kur can provide the substrate for development of AF in healthy canine atria, presumably via abbreviation of APO and ERP.
引用
收藏
页码:1304 / 1309
页数:6
相关论文
共 41 条
[21]   Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current [J].
Lagrutta, Armando ;
Wang, Jixin ;
Fermini, Bernard ;
Salata, Joseph J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03) :1054-1063
[22]   Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity [J].
Liu, LL ;
Nattel, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (02) :H805-H816
[23]   Electrophysiological and antiarrhythmic effects of the novel antiarrhythmic agent AZD7009:: a comparison with azimilide and AVE0118 in the acutely dilated right atrium of the rabbit in vitro [J].
Lofberg, Lena ;
Jacobson, Ingemar ;
Carlsson, Leif .
EUROPACE, 2006, 8 (07) :549-557
[24]   Atria selective prolongation by NIP-142, an antiarrhythmic agent, of refractory period and action potential duration in guinea pig myocardium [J].
Matsuda, T ;
Takeda, K ;
Ito, M ;
Yamagishi, R ;
Tamura, M ;
Nakamura, H ;
Tsuruoka, N ;
Saito, T ;
Masumiya, H ;
Suzuki, T ;
Iida-Tanaka, N ;
Itokawa-Matsuda, M ;
Yamashita, T ;
Tsuruzoe, N ;
Tanaka, H ;
Shigenobu, K .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 98 (01) :33-40
[25]   Dose-dependence of 4-aminopyridine plasma - Concentrations and electrophysiological effects in dogs potential relevance to ionic mechanisms in vivo [J].
Nattel, S ;
Matthews, C ;
De Blasio, E ;
Han, W ;
Li, DS ;
Yue, LX .
CIRCULATION, 2000, 101 (10) :1179-1184
[26]   New ideas about atrial fibrillation 50 years on [J].
Nattel, S .
NATURE, 2002, 415 (6868) :219-226
[27]   Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation [J].
Olson, Timothy M. ;
Alekseev, Alexey E. ;
Liu, Xiaoke K. ;
Park, Sungjo ;
Zingman, Leonid V. ;
Bienengraeber, Martin ;
Sattiraju, Srinivasan ;
Ballew, Jeffrey D. ;
Jahangir, Arshad ;
Terzic, Andre .
HUMAN MOLECULAR GENETICS, 2006, 15 (14) :2185-2191
[28]   Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation [J].
Pandit, SV ;
Berenfeld, O ;
Anumonwo, JMB ;
Zaritski, RM ;
Kneller, J ;
Nattel, S ;
Jalife, J .
BIOPHYSICAL JOURNAL, 2005, 88 (06) :3806-3821
[29]   Blocking characteristics of hERG, hNav1.5, and hKvLQT1/hminK after administration of the novel anti-arrhythmic compound AZD7009 [J].
Persson, F ;
Carlsson, L ;
Duker, G ;
Jacobson, I .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (03) :329-341
[30]   Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling [J].
Ramirez, RJ ;
Nattel, S ;
Courtemanche, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (04) :H1767-H1785